| scholarly article | Q13442814 |
| P50 | author | Lynne A. Opperman | Q42558995 |
| P2093 | author name string | Ogle RC | |
| Nolen AA | |||
| P2860 | cites work | Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. | Q30466407 |
| P433 | issue | 3 | |
| P304 | page(s) | 301-310 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro | |
| P478 | volume | 12 |
| Q39946596 | A TWIST in the fate of human osteoblasts identifies signaling molecules involved in skull development |
| Q36732493 | A review of hedgehog signaling in cranial bone development |
| Q35949127 | Application of Laser Capture Microdissection to Craniofacial Biology: Characterization of Anatomically Relevant Gene Expression in Normal and Craniosynostotic Rabbit Sutures |
| Q34248955 | Assessing age-related ossification of the petro-occipital fissure: laying the foundation for understanding the clinicopathologies of the cranial base. |
| Q35214686 | Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. |
| Q47103852 | BMP9 induces osteogenesis and adipogenesis in the immortalized human cranial suture progenitors from the patent sutures of craniosynostosis patients |
| Q92148399 | Cell Mechanics of Craniosynostosis |
| Q36570636 | Cellular response to force application at craniofacial sutures. |
| Q44850022 | Cloning of TgfβR1 and TgfβR2 and Likely Exclusion as Loci of Origin in a Rabbit Craniosynostotic Model |
| Q33720058 | Comparison of craniofacial phenotype in craniosynostotic rabbits treated with anti-Tgf-beta2 at suturectomy site. |
| Q34407265 | Cranial suture biology |
| Q38058778 | Craniofacial surgery, from past pioneers to future promise |
| Q93043741 | Current Approaches in the Development of Molecular and Pharmacological Therapies in Craniosynostosis Utilizing Animal Models |
| Q35684846 | Cytokine therapy for craniosynostosis |
| Q50494633 | Delivery of Transforming Growth Factor-β2-Perturbing Antibody in a Collagen Vehicle Inhibits Cranial Suture Fusion in Calvarial Organ Culture |
| Q45089272 | Delivery of Transforming Growth Factor-β3 Plasmid in a Collagen Gel Inhibits Cranial Suture Fusion in Rats |
| Q37357714 | Differential effects of TGF-beta1 and TGF-beta3 on chondrogenesis in posterofrontal cranial suture-derived mesenchymal cells in vitro |
| Q39851038 | Divergent Modulation of Adipose-Derived Stromal Cell Differentiation by TGF-β1 Based on Species of Derivation |
| Q35159500 | Dura mater stimulates human adipose-derived stromal cells to undergo bone formation in mouse calvarial defects |
| Q35796871 | Effects of Citalopram on Sutural and Calvarial Cell Processes. |
| Q33505673 | Estrogen/estrogen receptor alpha signaling in mouse posterofrontal cranial suture fusion |
| Q58165833 | Excessive retinoic acid inhibit mouse embryonic palate mesenchymal cell growth through involvement of Smad signaling |
| Q36054809 | Force-induced craniosynostosis in the murine sagittal suture |
| Q28573542 | Individual osteoblasts in the developing calvaria express different gene repertoires |
| Q39971776 | Inhibition of osteogenic differentiation of human mesenchymal stem cells |
| Q34456831 | Jaw muscles and the skull in mammals: the biomechanics of mastication |
| Q34192513 | Management of Craniosynostosis |
| Q48439703 | Mechanism of skull suture maintenance and interdigitation |
| Q53993822 | Mechanisms by which high-dose estrogen therapy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors. |
| Q38060056 | Models of cranial suture biology |
| Q34560898 | Molecular basis of cranial suture biology and disease: Osteoblastic and osteoclastic perspectives |
| Q36692622 | Remodeling the dentofacial skeleton: the biological basis of orthodontics and dentofacial orthopedics |
| Q34018035 | Retinoic acid enhances osteogenesis in cranial suture-derived mesenchymal cells: potential mechanisms of retinoid-induced craniosynostosis |
| Q37719717 | Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments |
| Q28073737 | Signaling mechanisms implicated in cranial sutures pathophysiology: Craniosynostosis |
| Q47743466 | Smad7 modulates TGFβ signaling during cranial suture development to maintain suture patency |
| Q39971441 | Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells |
| Q39155183 | TGF-β Family Signaling in Connective Tissue and Skeletal Diseases |
| Q28567708 | Tgf-beta1, Tgf-beta2, Tgf-beta3 and Msx2 expression is elevated during frontonasal suture morphogenesis and during active postnatal facial growth |
| Q34189687 | The BMP antagonist noggin regulates cranial suture fusion |
| Q33987011 | The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development |
| Q38032780 | The role of vertebrate models in understanding craniosynostosis |
| Q47301589 | Timing of Egf treatment differentially affects Tgf-beta2 induced cranial suture closure |
| Q41905018 | Tissue interactions between craniosynostotic dura mater and bone |
| Q38308866 | Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. |
| Q28578731 | Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration |
| Q33310098 | Unravelling the molecular control of calvarial suture fusion in children with craniosynostosis |
Search more.